Results 171 to 180 of about 576,009 (340)

[Occupational diseases of the airways and the lungs]. [PDF]

open access: yesInternist (Berl), 2021
Nowak D, Ochmann U, Mueller-Lisse UG.
europepmc   +1 more source

Mental Health in the Workplace: Situation Analyses, Germany [PDF]

open access: yes, 2000
[From Introduction] The ILO’s primary goals regarding disability are to prepare and empower people with disabilities to pursue their employment goals and facilitate access to work and job opportunities in open labour markets, while sensitising policy ...
Breucker, Gregor   +2 more
core   +1 more source

Keratinocyte carcinoma as an occupational disease [PDF]

open access: bronze, 2023
Jody Tate   +5 more
openalex   +1 more source

Socio‐economic inequalities and heart failure morbidity and mortality: A systematic review and data synthesis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 927-941, April 2025.
Abstract Socio‐economic status (SES) has been associated with incident and prevalent heart failure (HF), as well as its morbidity and mortality. However, the precise nature of the relationship between SES and HF remains unclear due to inconsistent data. This study aims to provide a comprehensive assessment and data synthesis of the relationship between
Abdul Shakoor   +8 more
wiley   +1 more source

Multivariate linear regression to predict association of non‐invasive arterial stiffness with cardiovascular events

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1141-1150, April 2025.
Abstract Background Arterial stiffness is a crucial factor in determining an increase in systolic blood pressure and pulse pressure and can also predict the development of cardiovascular disease (CVD). The purpose of this study was to examine the relationship between arterial stiffness and future CVD.
Susan Darroudi   +10 more
wiley   +1 more source

OCCUPATIONAL DISEASES

open access: yesInternational Journal of Clinical Practice, 1953
openaire   +2 more sources

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

open access: yesEnvironmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons   +17 more
wiley   +1 more source

From Brain Health to Brain Economy

open access: yes
Brain Health, EarlyView.
Yongjun Wang
wiley   +1 more source

Home - About - Disclaimer - Privacy